INTEGRA strides along the path towards net zero

Pipettes

INTEGRA strides along the path towards net zero

05 Aug, 2026

INTEGRA Biosciences has made significant inroads towards its net zero goals in the 3 years since it committed to the Science Based Targets initiative (SBTi). This scheme provides independent assessment and approval of companies’ carbon reduction targets according to strict criteria, and has been crucial in guiding the company’s progress in reducing greenhouse gas emissions.

INTEGRA has been working in partnership with a leading climate protection organisation, the myclimate foundation, to calculate its carbon footprint and implement practices to reduce carbon emissions. These actions have enabled the company to make great strides towards greener practices, including:

  • In-house generation of 970 MWh of photovoltaic electricity per year 
  • Increasing the use of renewable energy from 48 to 98 % since 2021 
  • 28 % reduction in Scope 3 emissions per turnover, notably by halving the volume of air freight, material savings on pipette tip boxes (50 %) and supporting e-mobility via company-owned charging stations

To achieve higher scores in the My Green Lab® ACT® Ecolabel program and provide more transparency for its customers, INTEGRA has also looked at product carbon footprints and holds gold status for its AUTO racks – currently the highest score in the tips for automation category.*

Visit the INTEGRA Biosciences website to learn more about the company’s initiatives and future plans.

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Valmet to deliver automation system for CO₂ liquefaction plant advancing Finland's green transition
Explore more Arrow
Petro Online
Why more industries are moving beyond fixed oil change schedules
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow